Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of the Society for Gynecologic Investigation
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Shigemasa, K.
Right arrow Articles by O'Brien, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shigemasa, K.
Right arrow Articles by Underwood, L. J.
Right arrow Articles by Beard, J.
Right arrow Articles by Tanimoto, H.
Right arrow Articles by Ohama, K.
Right arrow Articles by Parmley, T. H.
Right arrow Articles by O'Brien, T. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Ovarian Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Overexpression of Testisin, a Serine Protease Expressed by Testicular Germ Cells, in Expithelial Ovarian Tumor Cells

Kazushi Shigemasa, MD

Department of Obstetrics and Gynecology, Hiroshima University School of Medicine, Hiroshima, Japan; Department of Obstetrics and Gynecology, Asada General Hospital, Marugame, Japan; Departments of Obstetrics and Gynecology and Biochemistry and molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas kaz{at}mcai.med.hiroshima-u.ac.jp

Lowell J. Underwood, PhD

John Beard, BS

Hirotoshi Tanimoto, MD

Koso Ohama, MD

Tim H. Parmley, MD

Timothy J. O'Brien, PhD

Department of Obstetrics and Gynecology, Hiroshima University School of Medicine, Hiroshima, Japan; Department of Obstetrics and Gynecology, Asada General Hospital, Marugame, Japan; Departments of Obstetrics and Gynecology and Biochemistry and molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Objective: In a continued effort to identify and characterized secreted proteases that are overexpressed in ovarian carcinomas, we discovered the testisin protease as such a candidate. When this discovery was originally made, no data existed in the literature or in the GenBank database that identified such a gene. Our main objective was to determine whether this gene was overexpressed exclusively in ovarian tumor tissues compared with normal ovary and whether it was expressed in any other normal tissues.

Methods: mRNA was isolated and cDNA was prepared from 34 ovarian tumors (four adenomas, three low malignant potential tumors, and 37 carcinomas) and seven normal ovaries. The testisin mRNA expression level relative to internal control, ß-tubulin, was determined by Northern blot analysis and semiquantitative polymerase chain reaction (PCR).

Results: Northern blot hybridization showed that the testisin transcript was abundant in ovarian carcinoma but was not detected in normal ovary. On examination of Northern blots from normal fetal and adult tissues, only adult testis showed abundant transcripts of testisin. Semiquantitative PCR examination showed that the testisin mRNA levels in ovarian tumors of low malignant potential and in ovarian carcinomas were significantly higher than in normal ovaries (P < .01). Testisin mRNA level in ovarian carcinomas was also significantly higher than in ovarian adenomas (P < .05). Testisin overexpression rates in advanced stage (stage 2 or 3) diseases were significantly higher than that in early stage disease (stage 1) in ovarian carcinoma samples (P < .05).

Conclusions: The induction of the testisin transcript might contribute to the development, progression, and invasive or metastatic capacity of ovarian carcinomas.

Key Words: Testisin • serine prottease • mRNA • overexpression • ovarian tumor

Journal of the Society for Gynecologic Investigation, Vol. 7, No. 6, 358-362 (2000)
DOI: 10.1177/107155760000700608


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?